Please assess the completion status of the following clinical trial:

Trial Title: The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Participants must be pregnant.~2. Pregnant participants must have experienced quickening in course of gestation.~3. Participants must reside in an intervention or a counterfactual LGA.~Exclusion Criteria:~1. Non-pregnant residents in a counterfactual or an intervention LGA.~2. Non-residents of counterfactual or intervention LGA.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Community distribution of SP (Type: EXPERIMENTAL): All the eligible pregnant women were reached with SP either at health clinic and/or at community/household level with sulphadoxine-pyrimethamine (SP). Alerts and reminders were sent to them by community-based health volunteers ahead of subsequent SP doses.

Based on this trial design, predict the completion outcome and termination type (if applicable).